Pathology

Papers
(The median citation count of Pathology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation122
SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings69
The 2019 World Health Organization Classification of appendiceal, colorectal and anal canal tumours: an update and critical assessment52
Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent46
Clear cell papillary renal cell carcinoma: an update after 15 years35
NTRK-rearranged mesenchymal tumours: diagnostic challenges, morphological patterns and proposed testing algorithm34
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets34
Head-to-head evaluation on diagnostic accuracies of six SARS-CoV-2 serological assays33
Chromophobe renal cell carcinoma: current and controversial issues30
Clinical and molecular implications of NAB2-STAT6 fusion variants in solitary fibrous tumour27
Sample pooling is a viable strategy for SARS-CoV-2 detection in low-prevalence settings26
Circulating plasma miR-155 is a potential biomarker for the detection of SARS-CoV-2 infection26
The impact of viral transport media on PCR assay results for the detection of nucleic acid from SARS-CoV-225
The concept of mesothelioma in situ, with consideration of its potential impact on cytology diagnosis25
Evaluating errors in the laboratory identification of von Willebrand disease using contemporary von Willebrand factor assays25
PD-1/PD-L1, Treg-related proteins, and tumour-infiltrating lymphocytes are associated with the development of oral squamous cell carcinoma23
Evaluation of the BioFire Blood Culture Identification 2 panel and impact on patient management and antimicrobial stewardship22
A multicentre assessment of contemporary laboratory assays for heparin induced thrombocytopenia21
Urothelial carcinoma: variant histology, molecular subtyping, and immunophenotyping significant for treatment outcomes21
Granular necrosis: a distinctive form of cell death in malignant tumours20
Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes20
Angiomyolipoma of the kidney: from simple hamartoma to complex tumour20
INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer18
EGFR mutation exists in squamous cell lung carcinoma18
Malignant mesothelioma in situ: diagnostic and clinical considerations17
Staging of renal cell carcinoma: current progress and potential advances17
Emergence of Japanese encephalitis in Australia: a diagnostic perspective16
New developments in non-Hodgkin lymphoid malignancies16
HADHB, a fatty acid beta-oxidation enzyme, is a potential prognostic predictor in malignant lymphoma16
Silver nanoparticles as a bioadjuvant of antibiotics against biofilm-mediated infections with methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in chronic rhinosinusitis patients16
Molecular pathology of prostate cancer: a practical approach16
Core needle biopsy diagnosis of fibroepithelial lesions of the breast: a diagnostic challenge15
Laboratory diagnosis of severe acute respiratory syndrome coronavirus 214
SARS-CoV-2 viral load dynamics and real-time RT-PCR cycle threshold interpretation in symptomatic non-hospitalised individuals in New Zealand: a multicentre cross sectional observational study14
Prognostic features of Annexin A2 expression in prostate cancer13
Use of emerging testing technologies and approaches for SARS-CoV-2: review of literature and global experience in an Australian context13
Pancreatic acinar cell carcinomas and mixed acinar-neuroendocrine carcinomas are more clinically aggressive than grade 1 pancreatic neuroendocrine tumours13
Myeloid somatic mutation panel testing in myeloproliferative neoplasms13
Neuropathological findings in fatal COVID-19 and their associated neurological clinical manifestations12
Minimal residual disease in multiple myeloma: defining the role of next generation sequencing and flow cytometry in routine diagnostic use12
High MMP14 expression is predictive of poor prognosis in resectable hepatocellular carcinoma12
Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer12
Contamination of SARS-CoV-2 RT-PCR probes at the oligonucleotide manufacturer12
Machine learning and augmented human intelligence use in histomorphology for haematolymphoid disorders12
Clinical evaluation of four commercial immunoassays for the detection of antibodies against established SARS-CoV-2 infection12
Evaluation of molecular analysis in challenging ovarian sex cord-stromal tumours: a review of 50 cases12
Laboratory testing for platelet factor 4 antibodies: differential utility for diagnosis/exclusion of heparin induced thrombocytopenia versus suspected vaccine induced thrombotic thrombocytopenia11
Accuracy amidst ambiguity: false positive SARS-CoV-2 nucleic acid tests when COVID-19 prevalence is low11
Tumour-like lesions of the urinary bladder11
Comparison of PD-L1 immunohistochemical assays in advanced gastric adenocarcinomas using endoscopic biopsy and paired resected specimens11
Rapid detection of the widely circulating B.1.617.2 (Delta) SARS-CoV-2 variant11
Effect of macrotroponin on the utility of cardiac troponin I as a prognostic biomarker for long term total and cardiovascular disease mortality11
Stage T1 bladder cancer: diagnostic criteria and pitfalls11
EBV positive fibrin/chronic inflammation associated diffuse large B-cell lymphoma: an incidental finding associated with a breast implant11
Role of cell-free DNA in haematological malignancies11
Spindle cell/sclerosing rhabdomyosarcoma with a novel YAP1-MAML2 fusion in a 1-year-old: not all strongly TRK-expressing spindle cell sarcomas in infants are infantile fibrosarcomas!10
Detection and identification of dermatophyte fungi in clinical samples using a commercial multiplex tandem PCR assay10
Implementation and evaluation of a novel real-time multiplex assay for SARS-CoV-2: in-field learnings from a clinical microbiology laboratory10
Expression of PD-L1, cancer stem cell and epithelial–mesenchymal transition phenotype in non-small cell lung cancer10
An evaluation of existing manual blood film schistocyte quantitation guidelines and a new proposed method10
Variability in D-dimer reporting revisited10
Two cases of ZC3H7B-BCOR high grade endometrial stromal sarcoma with an extension on its morphological features10
Diffuse large B-cell lymphoma in a South African cohort with a high HIV prevalence: an analysis by cell-of-origin, Epstein–Barr virus infection and survival10
Diagnostic utility of PRAME, p53 and 5-hmC immunostaining for distinguishing melanomas from naevi, neurofibromas, scars and other histological mimics10
CAR-T cell therapy: practical guide to routine laboratory monitoring9
Clonal haematopoiesis of emerging significance9
An update on genomic aberrations in Spitz naevi and tumours9
The impact of grading scheme on non-muscle invasive bladder cancer progression: potential utility of hybrid grading schemes9
CD68-positive tumour associated macrophages, PD-L1 expression, and EBV latent infection in a high HIV-prevalent South African cohort of Hodgkin lymphoma patients9
Clinical evaluation of SARS-CoV-2 point-of-care antibody tests9
Alectinib induces marked red cell spheroacanthocytosis in a near-ubiquitous fashion and is associated with reduced eosin-5-maleimide binding9
Programmed cell death 1 ligand 1 (PD-L1) expression is associated with poor prognosis of malignant pleural mesothelioma patients with good performance status9
Electron microscopic observations in perfusion-fixed human non-alcoholic fatty liver disease biopsies9
GLI activated epithelioid cell tumour: report of a case and proposed new terminology9
Should the solid variant of odontogenic keratocyst and keratoameloblastoma be classified as the same entity? A clinicopathological analysis of nine cases and a review of the literature8
Comparison of a commercial real-time PCR panel to routine laboratory methods for the diagnosis of meningitis-encephalitis8
Genomic analysis of Lactococcus garvieae isolates8
The role of HER2 as a therapeutic biomarker in gynaecological malignancy: potential for use beyond uterine serous carcinoma8
Oral anticoagulation therapy: an update on usage, costs and associated risks8
Progression of mesothelioma in situ to invasive disease 4 years and 10 months after initial diagnosis8
Genomic characterisation of diffuse large B-cell lymphoma8
Urothelial carcinoma in situ: diagnostic update8
PRAME immunostain expression in sebaceous lesions, cutaneous carcinomas and adnexal structures8
SARS-CoV-2 N-gene mutation leading to Xpert Xpress SARS-CoV-2 assay instability8
PD-L1 expression in papillary thyroid cancer with and without lymphocytic thyroiditis: a cross sectional study8
Malignant solitary fibrous tumour of the prostate: four cases emphasising significant histological and immunophenotypical overlap with sarcomatoid carcinoma8
Atypia in breast pathology: what pathologists need to know8
NKX3.1 expression in cervical ‘adenoid basal cell carcinoma’: another gynaecological lesion with prostatic differentiation?8
Hybrid sclerosing epithelioid fibrosarcoma/low grade fibromyxoid sarcoma arising in the small intestine with distinct HEY1-NCOA2 gene fusion8
The neurotrophic tyrosine kinase receptor 1 (TrkA) is overexpressed in oesophageal squamous cell carcinoma8
Comparable survival outcome between acquired cystic disease associated renal cell carcinoma and clear cell carcinoma in patients with end-stage renal disease: a multi-institutional central pathology s8
SARS-CoV-2 antibodies in the Southern Region of New Zealand, 20208
Clinicopathological and molecular analysis of SIRT7 in hepatocellular carcinoma7
Stimulator of interferon genes (STING) immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney7
Decreased Nek9 expression correlates with aggressive behaviour and predicts unfavourable prognosis in breast cancer7
Tumour mutational burden: an overview for pathologists7
Diagnostic error, uncertainty, and overdiagnosis in melanoma7
Vancomycin variable Enterococcus (VVE), E. faecium, harbouring the vanA gene complex7
Melanoma with osseous or chondroid differentiation: a report of eight cases including SATB2 expression and mutation analysis7
Lymphatic invasion in acral and non-acral melanoma: a comparative, clinicoprognostic study of primary cutaneous melanoma according to tumour site7
Prevalence of T-cell antigen losses in mycosis fungoides and CD30-positive cutaneous T-cell lymphoproliferations in a series of 153 patients7
Is prostate infarction and acute urinary retention a possible complication of severe COVID-19 infection?7
Prostatic stromal proliferations: a review7
LncRNA PVT1 promotes the malignant progression of acute myeloid leukaemia via sponging miR-29 family to increase WAVE1 expression7
Benign mimics of prostate cancer7
Angiogenesis, programmed death ligand 1 (PD-L1) and immune microenvironment association in laryngeal carcinoma7
A Mycobacterium species for Crohn's disease?7
Erythrocyte interaction with neutrophil extracellular traps in coronary artery thrombosis following myocardial infarction7
Programmed death ligand 1 protein expression, histological tumour differentiation and intratumoural heterogeneity in pulmonary adenocarcinoma7
Institutional characterisation of water clear cell parathyroid adenoma: a rare entity often unrecognised by TC-99m-sestamibi scintigraphy6
Tumour infiltrating lymphocytes in oropharyngeal carcinoma: prognostic value and evaluation of a standardised method6
Weak positive SARS-CoV-2 N2 gene results using the Xpress Xpert assay: the need for an alternate interpretative criteria in a low prevalence setting6
Evaluation of MTAP and p16 immunohistochemical deficiency as surrogate marker for CDKN2A/B homozygous deletion in gliomas6
Assessment of analytical bias in ferritin assays and impact on functional reference limits6
Longitudinal evaluation of laboratory-based serological assays for SARS-CoV-2 antibody detection6
Gleason grade 5 prostate cancer: sub-patterns and prognosis6
Cytological diagnosis of mesothelioma in situ versus invasive mesothelioma6
A comparison of ThinPrep against four non-volatile transport media for HPV testing at or near the point of care6
Knowledge at what cost? An audit of the utility of panfungal PCR performed on bronchoalveolar lavage fluid specimens at a tertiary mycology laboratory6
Clinicopathological significance of multiple molecular features in undifferentiated and dedifferentiated endometrial carcinomas6
The utility and limitations of B- and T-cell gene rearrangement studies in evaluating lymphoproliferative disorders6
Metastatic melanoma and rare melanoma variants: a review6
Clinical correlation of lymphovascular invasion and Silva pattern of invasion in early-stage endocervical adenocarcinoma: proposed binary Silva classification system6
Reactive angioendotheliomatosis presenting as livedo racemosa secondary to propylthiouracil6
Design, implementation and clinical utility of next generation sequencing in myeloid malignancies: acute myeloid leukaemia and myelodysplastic syndrome6
Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial6
Brentuximab-related apoptotic colopathy6
Malignant transformation of fibrous dysplasia into osteosarcoma confirmed with TP53 somatic mutation and mutational analysis of GNAS gene6
Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing6
Multifocal anastomosing haemangioma of the kidney with intravascular growth and sinus fat invasion: a rare benign mimic of angiosarcoma6
Primary pancreatic spindle cell sarcoma with a TMEM106B::BRAF gene fusion treated with MEK inhibition6
Quantitative Pneumocystis jirovecii real-time PCR to differentiate disease from colonisation6
Inflammatory pseudotumour-like follicular dendritic cell tumour of the colon with plasmacytosis mimicking EBV-positive lymphoproliferative disorder5
Local genomic sequencing enhances COVID-19 surveillance in the Northern Territory of Australia5
Inflammatory pseudotumour arising secondary to VEXAS syndrome5
Blood culture quality assurance: what Australasian laboratories are measuring and opportunities for improvement5
Publication metrics: what do they mean?5
Sialadenoma papilliferum of the bronchus: focus on histological and genetic distinction from mixed squamous cell and glandular papilloma5
Comparison of three commercially available ELISA assays for anti-infliximab antibodies5
The path(ology) from reflux oesophagitis to Barrett oesophagus to oesophageal adenocarcinoma5
Using deep learning for quantification of cellularity and cell lineages in bone marrow biopsies and comparison to normal age-related variation5
Primary cutaneous methotrexate-associated B-cell lymphoproliferative disorders other than EBV-positive mucocutaneous ulcer: clinical, pathological, and immunophenotypic features5
Actinomycosis canaliculitis5
Reference intervals of spot urine copper excretion in preschool children and potential application in pre-symptomatic screening of Wilson disease5
A NUT carcinoma lacking squamous differentiation and expressing TTF15
Anastomosing haemangioma of the ovary with hilus cell hyperplasia5
Multi-site point of care assessment of Abbott ID NOW rapid molecular test for SARS-CoV-2 in a low-prevalence setting5
Prevalence and clinical significance of portal inflammation, portal plasma cells, interface hepatitis and biliary injury in liver biopsies from patients with non-alcoholic steatohepatitis5
Subtyping intestinal metaplasia in patients with chronic atrophic gastritis: an interobserver variability study5
High CHK2 protein expression is a strong and independent prognostic feature in ERG negative prostate cancer5
An overview of artificial intelligence/deep learning5
Whole genome sequencing for antimicrobial resistance mechanisms, virulence factors and clonality in invasive Streptococcus agalactiae blood culture isolates recovered in Australia5
Impact of new myeloma agents on the transfusion laboratory5
Diagnosis of rare subtypes of acute myeloid leukaemia and related neoplasms5
The biology of pancreatic cancer morphology5
HPV-driven anal neoplasia: review and recent developments5
Spinal calcifying pseudoneoplasm of the neuraxis (CAPNON) and CAPNON-like lesions: CAPNON overlapping with calcified synovial cysts4
Usual interstitial pneumonia: a review of the pathogenesis and discussion of elastin fibres, type II pneumocytes and proposed roles in the pathogenesis4
Why pathologists and oncologists should know about tumour-infiltrating lymphocytes (TILs) in triple-negative breast cancer: an Australian experience of 139 cases4
Cemento-osseous dysplasia is caused by RAS-MAPK activation4
The fluorescence enzyme immunoassay has greater utility than the gel precipitin test for the detection of specific IgG antibodies to Aspergillus fumigatus in the diagnosis of allergic bronchopulmonary4
Invasive poorly differentiated adenocarcinoma of the bladder following augmentation cystoplasty: a multi-institutional clinicopathological study4
Expression and localisation of methylthioadenosine phosphorylase (MTAP) in oral squamous cell carcinoma and their significance in epithelial-to-mesenchymal transition4
Cytotoxic CD8-positive T-lymphocyte infiltration in the lungs as a histological pattern of SARS-CoV-2 pneumonitis4
High expression of progesterone receptor may be an adverse prognostic factor in oestrogen receptor-negative/progesterone receptor-positive breast cancer: results of comprehensive re-evaluation of mult4
Clinicopathological analysis of myeloid sarcoma with megakaryocytic differentiation4
Independent validation of distinct clinicopathological features and prognosis among usual-type, mucinous-type and gastric-type endocervical adenocarcinoma categorised by new WHO classification (2020)4
Eosinophilic renal cell carcinoma with isolated MTOR mutation metastatic to the liver: a novel case4
Gonadoblastoma in individuals with a normal karyotype and no evidence of a disorder of sex development4
Proficiency testing for bacterial whole genome sequencing in assuring the quality of microbiology diagnostics in clinical and public health laboratories4
Prospective cohort study on the use of low molecular weight heparin calibrated anti-Xa assay for measurement of direct oral Xa inhibitors in ex vivo patient samples4
Report of a classic primordial odontogenic tumour and an unusual mixed odontogenic tumour with features of primordial odontogenic tumour: diagnostic implications4
IgG4-related disease in lung: a diagnostic challenge4
NTRK-rearranged spindle cell neoplasms: a clinicopathological and molecular study of 13 cases with peculiar characteristics at one of the largest institutions in China4
NKX3.1 immunohistochemistry is highly specific for the diagnosis of mesenchymal chondrosarcomas: experience in the Australian population4
Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclax4
Imaging flow cytometry shows monosomy 17 in circulating plasma cells in myeloma4
Gastrointestinal polyposis with associated cutaneous manifestations4
An update on genetic aberrations in T-cell neoplasms4
Agminated Spitz naevus with an activating HRAS Q61R mutation4
Epstein–Barr virus is a promoter of lymphoma cell metastasis4
ROS1 rearrangements in lung adenocarcinomas are defined by diffuse strong immunohistochemical expression of ROS14
Assessment of European Society of Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) guidelines in an Australian paediatric population4
Analytical sensitivity and specificity of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV assay4
Controversies in appendiceal pathology: mucinous and goblet cell neoplasms4
Recurrent plexiform angiomyxoid myofibroblastic tumour (PAMT) of the stomach with aggressive behaviour4
Highlights of infectious agents in tissue4
Comparative analysis of three laboratory based serological assays for SARS-CoV-2 in an Australian cohort4
Fibroblast activation protein as a potential theranostic target in brain metastases of diverse solid tumours3
Validation of phospholipase A2 receptor direct immunofluorescence staining in the diagnosis of primary membranous glomerulonephritis3
In-house multiplex ligation-dependent probe amplification assay for citrin deficiency: analytical validation and novel exonic deletions in SLC25A133
Dedifferentiated melanoma with MDM2 gene amplification mimicking dedifferentiated liposarcoma3
Elevated non-coding promoter mutations are associated with malignant transformation of melanocytic naevi to melanoma3
Spatial disparities in the reported incidence and survival of myeloproliferative neoplasms in Australia3
A novel prognostic nomogram for predicting survival in diffuse pleural mesothelioma3
Relative effects of direct spread, lymph node metastasis and venous invasion in relation to blood borne distant metastasis present at the time of resection of colorectal cancer3
BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting3
Gluten-free diet adherence and implications for the diagnosis of coeliac disease3
SMARCB1/INI1-deficient primary lung carcinoma with hepatic metastasis3
Prognostic significance of morphological patterns of Gleason grade 5 prostatic adenocarcinoma diagnosed on needle biopsy3
Idiopathic granulomatous mastitis and cystic neutrophilic granulomatous mastitis: two sides of the same coin or distinct entities?3
Biology and genetics of acquired and congenital melanocytic naevi3
YJ5 as an immunohistochemical marker of osteogenic lineage3
Histopathological typing in diffuse malignant epithelioid mesothelioma: implication for prognosis and molecular basis3
Increased diagnostic yield of routine multiplex PCR compared to clinician requested testing for detection of Trichomonas vaginalis3
The choice of anti-LEDGF/DFS70 assay matters: a comparative study of six assays3
Melanocytic naevi, melanocytomas and emerging concepts3
Design, development and deployment of a web-based patient registry for rare genetic lipid disorders3
Intravascular epithelioid haemangioma of deep soft tissue with novel SETD1B-FOSB gene rearrangement3
Prevalence of the EGFR T790M and other resistance mutations in the Australian population and histopathological correlation in a small subset of cases3
The Ring Study: an international comparison of PD-L1 diagnostic assays and their interpretation in non-small cell lung cancer, head and neck squamous cell cancer and urothelial cancer3
The clinicopathological spectrum of sclerosing epithelioid fibrosarcoma: report of an additional series with review of the literature3
The future of laboratory testing in chronic lymphocytic leukaemia3
Blue naevi and the blue tumour spectrum3
Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spread3
Clinical associations of SARS-CoV-2 viral load using the first WHO International Standard for SARS-CoV-2 RNA3
Improved performance of confirmatory assays for detecting dense fine speckled (DFS) 70 antibodies3
Frequent occurrence of low-level positive autoantibodies in chronic hepatitis C3
Proficiency testing for SARS-CoV-2 whole genome sequencing3
Regression in cutaneous melanoma: histological assessment, immune mechanisms and clinical implications3
Re: INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer3
Whole genome sequencing of Salmonella enterica serovar Saintpaul for elucidating the mechanisms of resistance to third generation cephalosporins3
Review of full blood count reference interval using a large cohort of first-time plasmapheresis blood donors3
Prolonged PCR positivity in elderly patients infected with SARS-CoV-23
Efficacy of training a deep learning model for mitotic count in breast carcinoma using opensource software3
IgG4-related pseudotumours: a series of 12 cases and a review of the literature3
Pathology utilisation during COVID-19 outbreaks beyond viral testing: routine coagulation and D-dimer testing3
Candida duobushaemulonii sepsis and Candida auris co-isolation following hospitalisation in Vietnam3
Intratubular large cell hyalinising Sertoli-cell neoplasia: a rare entity associated with Peutz–Jeghers syndrome3
Necrosis is an independent predictor of disease-free and overall survival in pancreatic well-differentiated neuroendocrine tumours (NETs): a proposal to include it in grading systems3
Panfungal PCR on formalin-fixed, paraffin-embedded tissue: to proceed or not proceed?3
Gynaecological or gastrointestinal origin? Recognising Müllerian neoplasms with gastrointestinal phenotype and determining the primary site in selected entities3
NTRK fusions in solid tumours: what every pathologist needs to know3
Intracranial mesenchymal tumour with EWSR1 gene rearrangement: the first report of intracranial mesenchymal tumour with FET-CREB fusion from India3
Incidental intravascular large B-cell lymphoma in a renal cell carcinoma3
Malignant gastrointestinal neuroectodermal tumour in soft tissue3
Meningioma sampling: how much is enough for the accurate grading of atypical meningiomas?3
Aberrant p16, p53 and Ki-67 immunohistochemistry staining patterns can distinguish solitary keratoacanthoma from cutaneous squamous cell carcinoma3
Contributions of genetics to the evolution of the diagnostic classification of renal cell neoplasia: a personal perspective3
Histo-blood group antigens and rotavirus vaccine virus shedding in Australian infants3
Assessing the performance of the Cepheid Xpert in identifying and differentiating methicillin-susceptible Staphylococcus aureus and methicillin-resistant Staphylococcus aureus from blood culture bottl3
Pitfalls in gastrointestinal tract haematopoietic lesions2
An unusual case of invasive lobular carcinoma with abundant extracellular mucin2
Precision diagnostics: integration of tissue pathology and genomics in cancer2
Tumour infiltrating lymphocyte density differs by meningioma type and is associated with prognosis in atypical meningioma2
Bone marrow fibrosis impact on response to azacitidine in myelodysplastic syndromes2
Unsupervised computational detection of measurable residual disease in chronic lymphocytic leukaemia2
Using long-read RNA sequencing to decipher the role of RNA isoforms in disease2
Characterisation of the protein expression of the emerging immunotherapy targets VISTA, LAG-3 and PRAME in primary uveal melanoma: insights from a southern French patient cohort2
Pathological assessment of tumour regression following neoadjuvant therapy in pancreatic carcinoma2
0.066633939743042